Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Last 12 months price action with 12-month analyst target path
As of May 8, 2026, Dillard's, Inc. (DDS) has a Wall Street consensus price target of $555.00, based on estimates from 13 covering analysts. With the stock currently trading at $553.46, this represents a potential upside of +0.3%. The company has a market capitalization of $6.60B.
Analyst price targets range from a low of $460.00 to a high of $650.00, representing a 34% spread in expectations. The median target of $555.00 aligns closely with the consensus average.
The current analyst consensus rating is Hold, with 2 analysts rating the stock as a Buy or Strong Buy,6 rating it Hold, and 5 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, DDS trades at a trailing P/E of 15.2x and forward P/E of 16.3x. Analysts expect EPS to grow -7.3% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Amazon.com, Inc..
Start ComparisonQuick answers to the most common questions about buying DDS stock.
The consensus price target for DDS is $555, close to the current price of $553.46 (0.3% implied move). Based on 13 analyst estimates, the stock appears fairly valued near current levels.
DDS has a consensus rating of "Hold" based on 13 Wall Street analysts. The rating breakdown is leaning bearish, with 5 Sell/Strong Sell ratings. The consensus 12-month price target of $555 implies 0.3% upside from current levels.
With a forward P/E of 16.321x, DDS trades at a relatively low valuation. The consensus target of $555 implies 0.3% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $650 for DDS, while the most conservative target is $460. The consensus of $555 represents the median expectation. These targets typically reflect 12-month expectations.
DDS is moderately covered, with 13 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 6 recommend Hold, and 5 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month DDS stock forecast based on 13 Wall Street analysts shows a consensus price target of $555, with estimates ranging from $460 (bear case) to $650 (bull case). The median consensus rating is "Hold".
DDS trades at a forward P/E ratio of 16.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 15.2x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
DDS appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $555 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
DDS analyst price targets range from $460 to $650, a 34% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $555 consensus represents the middle ground.